Form 10-Q Cellular Biomedicine For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cellular Biomedicine Group (CBMG) Tops Q1 EPS by 1c
May 18, 2015 6:13 AM EDTCellular Biomedicine Group (NASDAQ: CBMG) reported Q1 EPS of ($0.39), $0.01 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $603.4 thousand, versus $61.1 thousand reported last year.
For earnings history and earnings-related data on Cellular Biomedicine Group (CBMG) click here.
... More